CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells
Strategies to boost anti-tumor immunity are urgently needed to treat therapy-resistant late-stage cancers, including colorectal cancers (CRCs). Cytokine stimulation and genetic modifications with chimeric antigen receptors (CAR) represent promising strategies to more specifically redirect anti-tumor...
Main Authors: | Ali Bashiri Dezfouli, Mina Yazdi, Mohamed-Reda Benmebarek, Melissa Schwab, Stefanos Michaelides, Arianna Miccichè, Dirk Geerts, Stefan Stangl, Sarah Klapproth, Ernst Wagner, Sebastian Kobold, Gabriele Multhoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.883694/full |
Similar Items
-
Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy
by: Sihan Du, et al.
Published: (2022-08-01) -
Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection
by: Anna Lubkowska, et al.
Published: (2021-08-01) -
HSP27 and HSP70 expression in squamous cell carcinoma: An immunohistochemical study
by: Parviz Deyhimi, et al.
Published: (2012-01-01) -
Functionalized Hybrid Iron Oxide–Gold Nanoparticles Targeting Membrane Hsp70 Radiosensitize Triple-Negative Breast Cancer Cells by ROS-Mediated Apoptosis
by: Zhiyuan Wu, et al.
Published: (2023-02-01) -
Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC
by: Jakob Rinecker, et al.
Published: (2022-12-01)